Lumexa Imaging (NASDAQ:LMRI) Cut to Hold at Wall Street Zen

Wall Street Zen downgraded shares of Lumexa Imaging (NASDAQ:LMRI) from a buy rating to a hold rating in a report issued on Saturday,Wall Street Zen reports.

Several other brokerages also recently weighed in on LMRI. Deutsche Bank Aktiengesellschaft set a $16.00 price target on Lumexa Imaging in a report on Thursday, August 13th. Weiss Ratings raised shares of Lumexa Imaging from a “sell (e)” rating to a “sell (d)” rating in a research note on Thursday, June 25th. Finally, Barclays upped their price target on shares of Lumexa Imaging from $9.00 to $13.00 and gave the stock an “overweight” rating in a report on Friday, August 28th. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $17.33.

Lumexa Imaging Stock Performance

Shares of NASDAQ:LMRI opened at $11.39 on Friday. The firm has a fifty day simple moving average of $11.50 and a two-hundred day simple moving average of $10.65. The company has a quick ratio of 1.44, a current ratio of 1.44 and a debt-to-equity ratio of 1.40. The stock has a market capitalization of $1.09 billion and a P/E ratio of -23.24. Lumexa Imaging has a 52 week low of $6.45 and a 52 week high of $19.45.

Lumexa Imaging (NASDAQ:LMRI) last announced its earnings results on Wednesday, August 12th. The company reported $0.20 earnings per share for the quarter, beating the consensus estimate of $0.03 by $0.17. The firm had revenue of $264.16 million during the quarter. Lumexa Imaging has set its FY 2026 guidance at 0.710-0.770 EPS. On average, analysts expect that Lumexa Imaging will post 0.25 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Lumexa Imaging

Institutional investors and hedge funds have recently bought and sold shares of the company. Jupiter Topco LLC bought a new position in shares of Lumexa Imaging during the 2nd quarter worth $24,269,000. Janus Henderson Group PLC raised its holdings in shares of Lumexa Imaging by 5.4% in the first quarter. Janus Henderson Group PLC now owns 2,100,356 shares of the company’s stock valued at $18,063,000 after acquiring an additional 107,903 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund purchased a new stake in Lumexa Imaging in the fourth quarter worth about $27,750,000. BlackRock Inc. bought a new position in Lumexa Imaging during the 2nd quarter worth about $15,771,000. Finally, Brigade Capital Management LP bought a new stake in shares of Lumexa Imaging in the 2nd quarter valued at about $7,511,000.

Lumexa Imaging Company Profile

Lumexa Imaging, Inc (NASDAQ: LMRI) is an outpatient diagnostic imaging company that provides medical imaging services to patients and referring healthcare providers in the United States. Its services are designed to support the diagnosis, monitoring and management of a wide range of medical conditions.

The company’s imaging capabilities include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET/CT), ultrasound, mammography and X-ray services. Lumexa also provides related radiology and imaging-support services through its outpatient centers and other care-delivery arrangements.

Lumexa Imaging was formerly known as Akumin Inc and adopted the Lumexa Imaging name as part of its corporate rebranding.